MedTrace Logo

Reference Values for Body Composition Parameters and IGF-I in the Adult NordiNet® International Outcome Study

NCT01120977 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 150

Last updated 2011-11-07

No results posted yet for this study

Summary

The treatment of Growth Hormone deficiency (GHD) patients with GH, often induce fluid retention; this effect is dose dependent and temporary. The symptoms are swelling of soft tissue and joint stiffness. The objective of this study is to create bioelectric impedance/arm muscle area (BIA/AMA) reference data, as a measurement of hydration status, of healthy persons of both genders in the age 20-70 years.

Conditions

  • Growth Hormone Deficiency

Sponsors & Collaborators

  • University of Aarhus

    lead OTHER

Principal Investigators

  • Jens O Jørgnsen, Professor · University of Aarhus

Eligibility

Min Age
20 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2010-05-31
Primary Completion
2011-07-31
Completion
2011-08-31

Countries

  • Denmark

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01120977 on ClinicalTrials.gov